AI Chat Paper
Note: Please note that the following content is generated by AMiner AI. SciOpen does not take any responsibility related to this content.
{{lang === 'zh_CN' ? '文章概述' : 'Summary'}}
{{lang === 'en_US' ? '中' : 'Eng'}}
Chat more with AI
Home iLIVER Article
Article Link
Collect
Submit Manuscript
Show Outline
Outline
Show full outline
Hide outline
Outline
Show full outline
Hide outline
Commentary | Open Access

Interplay among oncogenic pathways governs hepatobiliary lineage decisions in liver cancer

Yonglong Pana,bXiaoping Chena,cZe-yang Dinga( )
Division of Hepato-Pancreato-Biliary Surgery, Hubei Key Laboratory of Hepato-Pancreatic-Biliary Diseases, Tongji Hospital, Tongji Medical College, Huazhong University of Science & Technology, Wuhan 430030, China
Key Laboratory of Molecular Biophysics, Ministry of Education, College of Life Science and Technology, Huazhong University of Science and Technology, Wuhan 430074, China
Key Laboratory of Organ Transplantation, Ministry of Education, National Health Commission, Chinese Academy of Medical Sciences, Wuhan 430030, China
Show Author Information

References

【1】
【1】
 
 
iLIVER

{{item.num}}

Comments on this article

Go to comment

< Back to all reports

Review Status: {{reviewData.commendedNum}} Commended , {{reviewData.revisionRequiredNum}} Revision Required , {{reviewData.notCommendedNum}} Not Commended Under Peer Review

Review Comment

Close
Close
Cite this article:
Pan Y, Chen X, Ding Z-y. Interplay among oncogenic pathways governs hepatobiliary lineage decisions in liver cancer. iLIVER, 2026, 5(2). https://doi.org/10.1016/j.iliver.2026.100241

7

Views

0

Crossref

0

Scopus

Received: 05 February 2026
Revised: 11 April 2026
Accepted: 27 April 2026
Published: 06 May 2026
© 2026 The Authors. Tsinghua University Press.

This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).